Seizing the strategic opportunities of emerging technologies by building up innovation system: monoclonal antibody development in China

BACKGROUND: Monoclonal antibodies (mAbs), as an emerging technology, have become increasingly important in the development of human therapeutic agents. How developing countries such as China could seize this emerging technological opportunity remains a poorly studied issue in prior literature. Thus,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Mao-Yu, Li, Jian, Hu, Hao, Wang, Yi-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634786/
https://www.ncbi.nlm.nih.gov/pubmed/26537659
http://dx.doi.org/10.1186/s12961-015-0056-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634786/
https://www.ncbi.nlm.nih.gov/pubmed/26537659
http://dx.doi.org/10.1186/s12961-015-0056-1

Ejemplares similares